0
ARTICLE |

Intraocular Sustained Drug Release Devices FREE

Alexander R. Irvine, MD
Arch Ophthalmol. 1995;113(1):25-26. doi:10.1001/archopht.1995.01100010027016
Text Size: A A A
Published online

The article on treatment of cytomegalovirus (CMV) retinitis with an intraocular sustained-release ganciclovir implant by Martin et al1 in the December 1994 issue of the Archives represents an important breakthrough. Past studies indicate that CMV retinitis occurs in 20% to 25% of all persons with the acquired immunodeficiency syndrome (AIDS); Douglass Jabs, MD, chair of the National Eye Institute Study of Ocular Complications of AIDS, estimated at a recent meeting of the American Academy of Ophthalmology that that figure is now approaching 50%, as medical advances are allowing patients to live longer with severely depressed CD4 cell counts. Dr Jabs stated that CMV retinitis is now the most common intraocular infection seen in large urban centers. This is thus a major problem, and the costs of present medical therapy with an indwelling venous catheter are huge, estimated at approximately $70 000 per year per patient. Statistics do not tell

REFERENCES

Martin DF, Parks DJ, Mellow SD, et al.  Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant: a randomized controlled clinical trial . Arch Ophthalmol . 1994;;112:1531-1539.
Spector SA, McKinley G, Drew WL, Stempien MJ, for the Syntex Ganciclovir Study Group. A randomized, double-blind study of the efficacy and safety of oral ganciclovir for the prevention of cytomegalovirus disease in HIV-infected persons. Presented at the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy; October 11, 1994; New Orleans, La.

First Page Preview

First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

Martin DF, Parks DJ, Mellow SD, et al.  Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant: a randomized controlled clinical trial . Arch Ophthalmol . 1994;;112:1531-1539.
Spector SA, McKinley G, Drew WL, Stempien MJ, for the Syntex Ganciclovir Study Group. A randomized, double-blind study of the efficacy and safety of oral ganciclovir for the prevention of cytomegalovirus disease in HIV-infected persons. Presented at the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy; October 11, 1994; New Orleans, La.

Correspondence

CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.